ArticleFrontiers in pharmacology2022

Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results.

María Luz Ruiz-Falcó Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.